Tau and GSK-3β are Critical Contributors to α-Synuclein-Mediated Post-Stroke Brain Damage
暂无分享,去创建一个
[1] Jian-Zhi Wang,et al. Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: A vicious cycle in Alzheimer neurodegeneration , 2022, EBioMedicine.
[2] R. Vemuganti,et al. MicroRNA miR-7 Is Essential for Post-stroke Functional Recovery , 2022, Translational Stroke Research.
[3] R. Vemuganti,et al. Tenascin-C induction exacerbates post-stroke brain damage , 2021, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[4] C. Jara,et al. Pathologically phosphorylated tau at S396/404 (PHF-1) is accumulated inside of hippocampal synaptic mitochondria of aged Wild-type mice , 2021, Scientific Reports.
[5] R. Vemuganti,et al. Deletion of ubiquitin ligase Nedd4l exacerbates ischemic brain damage , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] Esther J Pearl,et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research , 2020, PLoS biology.
[7] M. Alonso-Vanegas,et al. GSK3β and Tau Protein in Alzheimer’s Disease and Epilepsy , 2020, Frontiers in Cellular Neuroscience.
[8] P. Fraser,et al. Behavioral Abnormalities in Knockout and Humanized Tau Mice , 2020, Frontiers in Endocrinology.
[9] Hua Jiang,et al. Tau as a potential therapeutic target for ischemic stroke , 2019, Aging.
[10] R. Vemuganti,et al. Transient Focal Ischemia Significantly Alters the m6A Epitranscriptomic Tagging of RNAs in the Brain. , 2019, Stroke.
[11] Mary S. Lopez,et al. The microRNA miR-7a-5p ameliorates ischemic brain damage by repressing α-synuclein , 2018, Science Signaling.
[12] R. Pluta,et al. Tau Protein Dysfunction after Brain Ischemia , 2018, Journal of Alzheimer's disease : JAD.
[13] Emily C Turner,et al. Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits , 2018, Aging Cell.
[14] T. Fath,et al. Tau exacerbates excitotoxic brain damage in an animal model of stroke , 2017, Nature Communications.
[15] R. Vemuganti,et al. Circular RNA Expression Profiles Alter Significantly in Mouse Brain After Transient Focal Ischemia , 2017, Stroke.
[16] Wendy Noble,et al. Roles of tau protein in health and disease , 2017, Acta Neuropathologica.
[17] F. Guan,et al. GSK-3β as a target for protection against transient cerebral ischemia , 2017, International journal of medical sciences.
[18] R. Dempsey,et al. Poststroke Induction of α-Synuclein Mediates Ischemic Brain Damage , 2016, The Journal of Neuroscience.
[19] Qingwu Yang,et al. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats , 2016, Molecular Neurobiology.
[20] R. Vemuganti,et al. Long Noncoding RNA FosDT Promotes Ischemic Brain Injury by Interacting with REST-Associated Chromatin-Modifying Proteins , 2015, The Journal of Neuroscience.
[21] Wei Wang,et al. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats , 2015, Molecular Neurobiology.
[22] L. McCullough,et al. Inhibition of glycogen synthase kinase-3β enhances cognitive recovery after stroke: the role of TAK1 , 2015, Learning & memory.
[23] J. Goudreau,et al. GSK-3β dysregulation contributes to parkinson’s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein , 2014, Cell Death and Differentiation.
[24] Elisabeth L. Moussaud-Lamodière,et al. Alpha-synuclein and tau: teammates in neurodegeneration? , 2014, Molecular Neurodegeneration.
[25] Elisabeth L. Moussaud-Lamodière,et al. Alpha-synuclein and tau: teammates in neurodegeneration? , 2014, Molecular Neurodegeneration.
[26] G. Perry,et al. Phosphorylation of tau protein at sites Ser396–404 is one of the earliest events in Alzheimer's disease and Down syndrome , 2014, Neuropathology and applied neurobiology.
[27] D. Butterfield,et al. Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease. , 2014, Free radical biology & medicine.
[28] W. Rocca,et al. Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. , 2013, JAMA neurology.
[29] E. Masliah,et al. The many faces of α-synuclein: from structure and toxicity to therapeutic target , 2012, Nature Reviews Neuroscience.
[30] A. Bush,et al. GSK-3 in Neurodegenerative Diseases , 2011, International journal of Alzheimer's disease.
[31] S. Lule,et al. Alpha-Synuclein Aggregation Induced by Brief Ischemia Negatively Impacts Neuronal Survival in vivo: A Study in [A30P]alpha-Synuclein Transgenic Mouse , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[32] J. Trojanowski,et al. Synergistic Interactions between Aβ, Tau, and α-Synuclein: Acceleration of Neuropathology and Cognitive Decline , 2010, The Journal of Neuroscience.
[33] T. Duka,et al. α‐Synuclein contributes to GSK‐3β‐catalyzed Tau phosphorylation in Parkinson's disease models , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] R. Postina. A closer look at alpha-secretase. , 2008, Current Alzheimer research.
[35] J. Trojanowski,et al. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.
[36] L. Mucke,et al. Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.
[37] J. Simpkins,et al. Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. , 2007, Biochimica et biophysica acta.
[38] W. Gordon-Krajcer,et al. Differential Changes in Phosphorylation of Tau at PHF-1 and 12E8 Epitopes During Brain Ischemia and Reperfusion in Gerbils , 2007, Neurochemical Research.
[39] J. Goudreau,et al. Alpha‐Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[40] K. Fukunaga,et al. Hyperphosphorylation at serine 199/202 of tau factor in the gerbil hippocampus after transient forebrain ischemia. , 2006, Biochemical and biophysical research communications.
[41] A. Lang,et al. Interface between tauopathies and synucleinopathies: A tale of two proteins , 2006, Annals of neurology.
[42] J. Trojanowski,et al. Tau and α-Synuclein Pathology in Amygdala of Parkinsonism-Dementia Complex Patients of Guam , 2002 .
[43] Nancy Ratner,et al. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin‐based motility , 2002, The EMBO journal.
[44] J. Trojanowski,et al. Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam. , 2002, The American journal of pathology.